【摘要】 目的 :对选择性动脉化疗灌注联合微量泵输注治疗大肠癌的价值进行探讨。方法 :用 Seldinger技术对 31例大肠癌病例行选择性动脉灌注化疗药物 (Mitomycin、 Cisplatin)。保留导管 ,联合微量泵连续输注药物 (Cisplatin Floxuridine)。结果 :治疗后 ,患者临床症状改善明显 ,完全缓解 1例 ,部分缓解 2 3例 ,无变化 6例 ,恶化 1例。有效率 77.4 %。 1,2 ,3年生存率分别为 74 .2 % ,5 4 .8%与 35 .5 % ,其中 9例于治疗 2次后行根治性切除。结论 :选择性动脉化疗灌注联合微量泵输注治疗大肠癌是一种安全有效的治疗方法更多还原

【Abstract】 Objective: To evaluate the clinical value of selective arterial infusion chemotherapy and infusionpump infusion chemotherapy Methods: 31 patients received by Seldinger technology the chemical (Mitomycin Cisplatin) which was infused via arteria cocrrespondent After that the chemical (Cisplatin, Floxuridine) was infused by infusionpump Results: After the treatment, the patients’ clinical symptoms were improved, 9 patients underwente operation after two times of interventional therapy Once case was completely relieved and 23 cases were partially relieved, with a total effective rate of 77 4% The survial rates for 1,2 and 3 years were 74 2%,54 8%,35 5% respectively Conclusion: Selective and arterial infusion chemotherapy and infusionpump infusion chemotherapy for colorectal cancer was a safe and effective treatment更多还原